CPH on it's own were likely going to fail long-term. There wasn't much doubt about that (unless management changed which wasn't going to happen).
However now holders may stand a chance with the new Company in their TRIP share holdings.
Probably the most positive (and legitimising) thing is William Lay is joining the team.
Mr. William Lay, previously Associate Director, M&A at Canopy Growth appointed Executive Vice President and Chief Strategy Officer to assist in growth trajectory - Mr. Lay has overseen and/or supported over C$5Bn in cannabis M&A transactions.
But I agree, the sooner they can get EverBlu out of the picture the better. There's a reason they call it conflicts of interest and why it's a huge no-no in business.
- Forums
- ASX - By Stock
- CPH
- 40c party Thy Hybrid Lab
40c party Thy Hybrid Lab, page-75
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)